PLGA (50:50)

PLGA (50:50) (poly (lactic-co-glycolic acid) (50:50) ) is a copolymer of poly lactic acid (PLA) and poly glycolic acid (PGA) which can be used to fabricate devices for drug delivery and tissue engineering applications.

Product Specifications

CAS Number

[34346-01-5]

Product Name Alternative

Poly (lactic-co-glycolic acid) (50:50)

UNSPSC

12352211

Target

Biochemical Assay Reagents

Type

Oligonucleotides

Related Pathways

Others

Field of Research

Others

Assay Protocol

https://www.medchemexpress.com/plga-50-50.html

Purity

99.0

Solubility

DMSO : 100 mg/mL (ultrasonic)

Smiles

O=C(O)C(C)OC(CO[H])=O.[x].[y]

Molecular Formula

(C3H6O3) n. (C2H4O3) n

Molecular Weight

10000-20000

References & Citations

[1]Makadia HK, et al. Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier. Polymers (Basel) . 2011 Sep 1;3 (3) :1377-1397.|[2]Chung TW, Tsai YL, Hsieh JH, Tsai WJ. Different ratios of lactide and glycolide in PLGA affect the surface property and protein delivery characteristics of the PLGA microspheres with hydrophobic additives. J Microencapsul. 2006;23 (1) :15-27. |[3]Mura S, et al. Influence of surface charge on the potential toxicity of PLGA nanoparticles towards Calu-3 cells. Int J Nanomedicine. 2011;6:2591-605.